Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

How we supported forecasting for a new vaccine by identifying the optimal pricing strategy

How we supported forecasting for a new vaccine by identifying the optimal pricing strategy

Our client was looking to identify the price point that would maximise revenue from their new vaccine across 8 emerging markets in Latin America and Asia Pacific, as well as establish long-term projections for their forecasting model. In parallel, they needed to ensure widespread and rapid market penetration of the vaccine, taking into account factors such as consumer socio-economic group, age and household composition.
 

read more »

Client Testimonial “Research Partnership is one of the best agencies working in China & Emerging Markets..."

“Research Partnership is one of the best agencies working in China & Emerging Markets. The project team was simply brilliant and very responsive to all client needs. They helped me to manage almost 15 countries and did an extremely wonderful job. Additionally, a fantastic support and co-ordination of the Scientific Publication we are aiming for. Simply the best!”

read more »

  • Posted by Marc Yates
  • March 12, 2020
  • Guides

Real-world evidence

Real-world evidence

A guide to conducting market research for scientific publication

Publishing market research in a peer-reviewed journal transforms the study's findings from real world data into real world evidence, which potentially has a much greater impact. But what are the challenges for conducting market research projects intended for publication in a peer-reviwed journal? 

read more »

  • Posted by Paul Reed
  • February 24, 2020
  • Videos

Conducting research in Latin America

Paul Reed explores the opportunities in this exciting region, which has diverse and unique healthcare systems, an ageing and declining population, and a rise in the popularity of digital communication channels, especially WhatsApp. 

read more »

How we helped determine the next groundbreaking development in a hard-to-treat respiratory disease

How we helped determine the next groundbreaking development in a hard-to-treat respiratory disease

Our client wanted to understand the current management in a complex therapy area, as treatment regimens require a combination of multiple drugs. Furthermore, the disease is most prevalent in emerging, hard-to-access markets. Understanding of drugs and treatment regimen preferences were required to help gauge likely success of the client’s new formulation in development, which would be part of a new regimen paradigm. As well as understanding current preferences and reactions to the new drug and regimen, the research needed to test several potential outcomes for the new formulation and assess performance against future new regimens likely to be available at the time of launch.

read more »